Presentation of the company and the development of linaprazan glurate from Redeye Transactions
![Cinclus Redeye Growth Day 03](/media/vxcohjsp/cinclus_redeye-growth-day-03.jpg?rmode=max&width=1053&v=1dabe5a18260590)
Here you can watch the full presentation of Cinclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at Redeye Transactions June 13th.
Cinclus Pharma: CEO Christer Ahlberg presents at Redeye Transactions – 13th June 2024